Literature DB >> 8613428

Genomic organization of human papillomavirus type 18 in cervical cancer specimens.

K Kitagawa1, H Yoshikawa, T Onda, T Kawana, Y Taketani, H Yoshikura, A Iwamoto.   

Abstract

It has been reported that cervical cancers positive for human papillomavirus (HPV) 18 have a poorer prognosis than those with other HPV types. To gain a better understanding of the aggressive character of HPV 18-positive cancers, we examined the difference in genomic organization between HPV 18 and HPV 16 harbored in cervical cancers. We amplified E1 and E2 genes from 9 HPV 18-positive and 31 HPV 16-positive cervical cancers by polymerase chain reaction (PCR). At least one of the two early genes was missing in 3 out of 9 HPV 18-positive cancers, while both PCRs were positive in all 31 HPV 16-positive cancers (P < 0.05). We then analyzed the 9 HPV 18-positive cancers by 15 contiguous polymerase chain reactions covering collectively the whole HPV 18 genome. In addition to the three with a deletion of the E1 or E2 gene, one had a deletion in the E5 and L2 genes and one had an insertion in the long control region. The frequent alterations in genomic organization, especially preferential deletion of the E1 or E2 gene, may be related to the more aggressive properties of HPV 18-positive cervical cancers.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8613428      PMCID: PMC5921097          DOI: 10.1111/j.1349-7006.1996.tb00215.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  26 in total

1.  Human papillomavirus genotype as a prognostic indicator in carcinoma of the uterine cervix.

Authors:  J Walker; J D Bloss; S Y Liao; M Berman; S Bergen; S P Wilczynski
Journal:  Obstet Gynecol       Date:  1989-11       Impact factor: 7.661

2.  Amplification and typing of multiple cervical cancer-associated human papillomavirus DNAs using a single pair of primers.

Authors:  H Yoshikawa; T Kawana; K Kitagawa; M Mizuno; H Yoshikura; A Iwamoto
Journal:  Int J Cancer       Date:  1990-05-15       Impact factor: 7.396

3.  Transcriptional trans-activation by the human papillomavirus type 16 E2 gene product.

Authors:  W C Phelps; P M Howley
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

4.  Integration and transcription of human papillomavirus type 16 and 18 sequences in cell lines derived from cervical carcinomas.

Authors:  H Shirasawa; Y Tomita; S Sekiya; H Takamizawa; B Simizu
Journal:  J Gen Virol       Date:  1987-02       Impact factor: 3.891

5.  Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters.

Authors:  H Romanczuk; F Thierry; P M Howley
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

6.  Analysis of individual human papillomavirus types in cervical neoplasia: a possible role for type 18 in rapid progression.

Authors:  R J Kurman; M H Schiffman; W D Lancaster; R Reid; A B Jenson; G F Temple; A T Lorincz
Journal:  Am J Obstet Gynecol       Date:  1988-08       Impact factor: 8.661

7.  Genome amplification of human papillomavirus types 16 and 18 in cervical carcinomas is related to the retention of E1/E2 genes.

Authors:  J Berumen; L Casas; E Segura; J L Amezcua; A Garcia-Carranca
Journal:  Int J Cancer       Date:  1994-03-01       Impact factor: 7.396

8.  Possible prognostic significance of human papillomavirus type in cervical cancer.

Authors:  W Barnes; G Delgado; R J Kurman; E S Petrilli; D M Smith; S Ahmed; A T Lorincz; G F Temple; A B Jenson; W D Lancaster
Journal:  Gynecol Oncol       Date:  1988-03       Impact factor: 5.482

9.  Transformation of rat 3Y1 cells by human papillomavirus type-18 DNA.

Authors:  S Watanabe; K Yoshiike
Journal:  Int J Cancer       Date:  1988-06-15       Impact factor: 7.396

10.  Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers.

Authors:  H Yoshikawa; T Kawana; K Kitagawa; M Mizuno; H Yoshikura; A Iwamoto
Journal:  Jpn J Cancer Res       Date:  1991-05
View more
  5 in total

1.  The integration of HPV-18 DNA in cervical carcinoma.

Authors:  S A Corden; L J Sant-Cassia; A J Easton; A G Morris
Journal:  Mol Pathol       Date:  1999-10

2.  Rapid and sensitive detection of physical status of human papillomavirus type 16 DNA by quantitative real-time PCR.

Authors:  Shoji Nagao; Mitsuo Yoshinouchi; Yasunari Miyagi; Atsushi Hongo; Junichi Kodama; Sachio Itoh; Takafumi Kudo
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

3.  Human papillomavirus type 16 (HPV-16) genomes integrated in head and neck cancers and in HPV-16-immortalized human keratinocyte clones express chimeric virus-cell mRNAs similar to those found in cervical cancers.

Authors:  Michael J Lace; James R Anson; Jens P Klussmann; Dong Hong Wang; Elaine M Smith; Thomas H Haugen; Lubomir P Turek
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

4.  Upstream regulatory region alterations found in human papillomavirus type 16 (HPV-16) isolates from cervical carcinomas increase transcription, ori function, and HPV immortalization capacity in culture.

Authors:  Michael J Lace; Christina Isacson; James R Anson; Attila T Lörincz; Sharon P Wilczynski; Thomas H Haugen; Lubomír P Turek
Journal:  J Virol       Date:  2009-05-20       Impact factor: 5.103

5.  Is human papillomavirus genotype an influencing factor on radiotherapy outcome? Ambiguity caused by an association of HPV 18 genotype and adenocarcinoma histology.

Authors:  Joo-Young Kim; Byung Ho Nam; Jin-Ah Lee
Journal:  J Gynecol Oncol       Date:  2011-03-31       Impact factor: 4.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.